PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen

Share "PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen"

N/A

Protected

Ano acadêmico: 2023

Info

Descarregar agora

Protected

Academic year: 2023

Share "PDF VI.2 Elements for a public summary VI.2.1 ... - Lægemiddelstyrelsen"

Copied!

Carregando.... (Ver texto completo agora)

Descarregar agora ( 10 páginas )

Texto

Referências

Descarregar agora ( PDF - 10 páginas - 564.31 KB )

Documentos relacionados

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN DATE

VI.2.4 Summary of safety concerns Important identified risks Risk What is known Preventability Symptoms when stopping venlafaxine discontinuation symptoms or withdrawal syndrome

Documentos relacionados

•The UK population has one of the highest average serum cholesterol levels in the world

PDF VI.2 Elements for a Public Summary - Lægemiddelstyrelsen

VI.2 Elements for a Public Summary

VI.2 ELEMENTS FOR A PUBLIC SUMMARY

VI.2 Elements for a Public Summary

,with the World Health Organisation (WHO) estimating that depression affects 350 million people with the burden 50% higher for females than males.

Page 14 of 37 VI.2 Elements for a public summary

7.1.2 Part VI.2.2 Summary of treatment benefits